Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IAI | 184.98 | 2.37 | +1.30% |
| iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI) | |||
| SPXE | 81.61 | 0.65 | +0.80% |
| ProShares S&P 500 Ex-Energy ETF (SPXE) | |||
| LFDR | 178.28 | N/A | N/A |
| LifeX Durable Income ETF | |||
| CPZ | 12.41 | N/A | N/A |
| Calamos Long/Short Equity & Dynamic Income Trust | |||
| MUSQ | 25.51 | N/A | N/A |
| MUSQ Global Music Industry Index ETF (MUSQ) | |||
A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with VIR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then VIR could also see price increases.
| Ticker / NAME | Correlation To PVLA | 1D Price Change % | ||
|---|---|---|---|---|
| PVLA | 100% | -3.08% | ||
| VIR - PVLA | 45% Loosely correlated | -3.63% | ||
| BEAM - PVLA | 44% Loosely correlated | -6.92% | ||
| TRVI - PVLA | 43% Loosely correlated | -2.61% | ||
| EDIT - PVLA | 42% Loosely correlated | -8.91% | ||
| DNTH - PVLA | 42% Loosely correlated | -1.32% | ||
More | ||||
Industry Biotechnology
PVLA saw its Momentum Indicator move above the 0 level on October 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 104 similar instances where the indicator turned positive. In 88 of the 104 cases, the stock moved higher in the following days. The odds of a move higher are at 85%.
The Moving Average Convergence Divergence (MACD) for PVLA just turned positive on October 23, 2026. Looking at past instances where PVLA's MACD turned positive, the stock continued to rise in 29 of 39 cases over the following month. The odds of a continued upward trend are 74%.
PVLA moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PVLA crossed bullishly above the 50-day moving average on November 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +10.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where PVLA advanced for three days, in 219 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The 10-day RSI Indicator for PVLA moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 20 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PVLA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
PVLA broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PVLA entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.688) is normal, around the industry mean (3.498). P/E Ratio (-36.272) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. PVLA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PVLA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.